Chemomab Therapeutics Ltd. American Depositary Share — Rendiconto Finanziario Trimestrale (NASDAQ:CMMB) | MetaTrader

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Market Capitalization 11.8672 M
Employee 12
Founded 2011
CEO N/A
Website www.chemomab.com
Headquarter Israel
FIGI BBG00N0PMGK1
Industry Technology

Ricavi totali

Utile netto

Utile base per azione (EPS base)

Debito totale

Liquidità libera

Disponibilità liquide e mezzi equivalenti

11.87 M Capitalizzazione di mercato

Notizie

Chemomab’s nebokitug shows disease-modifying potential in PSC trial

Chemomab riporta dati positivi a 48 settimane per il farmaco PSC nebokitug

Chemomab reports positive 48-week data for PSC drug nebokitug

ALKS to Enter Sleep Disorder Market With $2.1B Avadel Acquisition

Best Momentum Stocks to Buy for Oct. 23

New Strong Buy Stocks for Oct. 23: MQ, GES and More

SNY's Efdoralprin Alfa Meets Key Endpoints in Rare Disease Study

Roche's Gazyva Secures FDA Nod for Label Expansion in Lupus Nephritis

NVO's Rybelsus Gets FDA Nod to Reduce Heart Risk in Diabetes Patients

ESPR Aims to Diversify With Rare Liver Disease Candidate, Stock Up

NVO and LLY Stocks Slide as Trump Signals Price Cuts for GLP-1 Drugs

Viatris Acquires Aculys Pharma to Expand Neurology Portfolio in Japan